Renal scarring is the most significant predictor of breakthrough febrile urinary tract infection in patients with simplex and duplex primary vesico-ureteral reflux
Autor: | Alexander L. Macdonald, Stavros P. Loukogeorgakis, Katherine M. Burnand, Nisha Rahman, M.K. Farrugia, Diane De Caluwe, Katherine Wessely |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
medicine.medical_specialty Cystography Voiding cystourethrogram Urology Urinary system 030232 urology & nephrology urologic and male genital diseases Cicatrix 03 medical and health sciences 0302 clinical medicine 030225 pediatrics medicine Humans Antibiotic prophylaxis Retrospective Studies Vesico-Ureteral Reflux Univariate analysis medicine.diagnostic_test business.industry Infant medicine.disease Renal dysplasia female genital diseases and pregnancy complications Dysplasia Dimercaptosuccinic acid Urinary Tract Infections Pediatrics Perinatology and Child Health business Radioisotope Renography medicine.drug |
Zdroj: | Journal of Pediatric Urology. 16:189.e1-189.e7 |
ISSN: | 1477-5131 |
DOI: | 10.1016/j.jpurol.2019.11.018 |
Popis: | Summary Introduction The association of high-grade vesico-ureteral reflux (VUR) with renal dysplasia and/or scarring is well-established, and the combination of these factors has been shown to decrease the likelihood of VUR resolution. Other VUR parameters have similarly been shown to be associated with VUR non-resolution, including VUR grade and timing at cystography, associated urinary tract anatomical abnormalities, and bladder dysfunction. Objective To establish independent risk factors that can predict symptomatic persistence of VUR. Design This was a single-centre study (2011–2017) including consecutive prospectively collected patients with primary VUR on voiding cystourethrogram (VCUG). Patients with dilating VUR also underwent renography (dimercaptosuccinic acid [DMSA] or 99m-technetium mercaptoacetyltriglycine [99mTc-MAG3]). All patients were initially managed medically with antibiotic prophylaxis. Primary outcome was febrile culture-positive breakthrough urinary tract infection (BT-UTI). Demographic parameters, as well as VUR grade, VUR timing at cystography, presence of ureteral anomaly, VUR index (VURx), and differential renal function (DRF) or scarring were analysed to determine independent predictors. Results A total of 61 patients (41 male, of whom 7 circumcised at presentation) were studied. VUR was diagnosed following investigation of prenatal hydronephrosis in 37 patients (62%) and following a febrile UTI in 22 (37%). Median [range] follow-up period was 38 [12–84] months. Data from a total of 77 refluxing renal units (RUs) were used for analysis. Analysis of VCUG data demonstrated that high VURx might be a potential significant predictor of breakthrough UTI (RR: 1.7, 95% CI: 1.1–2.7, p Discussion Multiple factors have been shown to be significant predictors of radiological VUR resolution. Univariate analysis of these factors suggests that only scarring on DMSA and VURx are significant predictors of symptomatic non-resolution. On multivariate analysis, scarring on DMSA was the only significant predictive variable. This information will be useful in targeting investigation and treatment in susceptible patients and when counselling families. Conclusion Renal scarring is the most significant risk factor for breakthrough UTI in primary VUR patients and could be used to determine those at risk of symptomatic VUR persistence. Download : Download high-res image (121KB) Download : Download full-size image Summary Figure . Urinary tract infection (UTI)-free survival in vesico-ureteral reflux (VUR) patients with (green/+) or without (red/-) renal scarring/dysplasia. ∗p |
Databáze: | OpenAIRE |
Externí odkaz: |